|
|
|
Nov 19, 2009 (SmarTrend(R) Research Reports via COMTEX) -- SmarTrend, the proprietary pattern recognition system, has made available a free sample copy of our premium research report on (NASDAQ:XNPT) at...
Astellas Pharma Inc. and XenoPort, Inc. (NASDAQ:XNPT) today announced that a new drug application (NDA) has been filed with the Pharmaceuticals and Medical Device Agency (PMDA) in Japan for ASP8825 (gabapentin enacarbil), also...
The Cheapest Online-Drugstore. Always Special Offers in Our Online-Drugstore. baclofen online. + Free bonus pills for every order! + Fast worldwide shipping! 30 days money back guarantee! Free AirMail & Courier s...
Stock quotes in this article: ) -- Another U.S. Food and Drug Administration drug review -- delayed. This time, it's Cadence Pharmaceuticals , which said Friday that FDA is pushing back review of its intravenous acetaminophen...
Nov 10, 2009 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend, our proprietary pattern recognition system, called a Downtrend for XenoPort (NASDAQ:XNPT) on October 22, 2009 at $18.58. Since then, XenoPort has returned 10.6% as...
Thanksgiving is just a few short weeks away, but a few small drug companies are looking to give thanks for the Food and Drug Administration a little early. Cadence Pharmaceuticals (Nasdaq: CADX) is trying to get an approval for...
In BW 5972 issued November 6, 2009: First graph, second sentence of release (dated November 6, 2009) should read: The NDA currently under review by the FDA is for the treatment of moderate-to-severe primary Restless Legs...
Stock quotes in this article: ) management backed away Monday from its previously stated promise of a Big Pharma partnership for its diabetes drug XOMA 052 by year's end. The company now says that potential partners may need...
Stock quotes in this article: ) -- Shares of Ariad Pharmaceuticals( Cory Kasimov boosted his Ariad rating Monday morning based on two upcoming catalysts from the company's drug pipeline: 1) Results from a phase I, proof of...
7:59AM McDonald's reports October same store sales of +3.3% 61.72 : Co announces October same store sales of +3.3%. 7:40AM Fuqi Intl beats by $0.29, misses on revs; guides Q4 EPS in-line, revs in-line 23.33 : Reports Q3 (Sep)...
